When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KRTX - Karuna Therapeutics will not develop KarXT in Pain
Karuna Therapeutics Inc.
Karuna Therapeutics (NASDAQ:KRTX)-7% post market, after topline results from Phase 1b (KAR-020) trial of KarXT on experimentally induced pain, were inconclusive and do not provide sufficient evidence of an analgesic benefit of KarXT compared to placebo.
More news on: Karuna Therapeutics, Inc., Healthcare stocks news, Stocks on the move,